Vu D D, Tuchweber B, Plaa G L, Yousef I M
Department of Pharmacology, University of Montreal, Canada.
Biochim Biophys Acta. 1992 Jun 5;1126(1):53-9. doi: 10.1016/0005-2760(92)90216-i.
It has been shown that lithocholic glucuronide is more cholestatic than lithocholic acid (LCA), as well as its taurine and glycine conjugates. Furthermore, LCA hydroxylation is thought to be a major detoxifying mechanism. Therefore, the role of LCA glucuronidation and hydroxylation was investigated during the development of LCA-induced cholestasis and recovery from it. Male rats received a bolus intravenous injection of [14C]LCA (12 mumol/100 g body weight) and bile samples were collected every 30 min for 5 h. Bile flow (BF) was reduced immediately after LCA injection, dropping to 40% of basal BF at 60 min. It then started to increase, reaching normal bile flow values at 3.5 h. Morphologically, canalicular lesions were dominant at 60 min and virtually absent at 2 h. At 60 min (maximal cholestasis), 30% of the LCA injected was secreted in bile, 20% was found in plasma while the other 50% was recovered in the liver and distributed mainly in plasma membranes, microsomes and cytosol. At the end of the experiment (normal BF), 20% of the LCA injected was still in the liver but was present mainly in the cytosol. In bile, within 30 min after injection, 46% of the LCA secreted was lithocholic glucuronide, 24% was conjugated with taurine and glycine, and 21% was in the form of hydroxylated bile acids. During the recovery period, lithocholic glucuronide secretion decreased to 18-25%. Taurine and glycine conjugate secretion increased to a maximum of 43% at 60 min, after which it was reduced to 21-28%. In contrast, hydroxylated metabolites were elevated during the recovery periods, reaching a maximum (45%) at 120 min and remaining constant thereafter. These results suggest that: (i) LCA binding to plasma membranes and microsomes appeared to correlate with the development of cholestasis; (ii) LCA glucuronidation may initiate and/or contribute to LCA-induced cholestasis; and (iii) hydroxylation predominates during recovery from cholestasis.
已表明,石胆酸葡萄糖醛酸苷比石胆酸(LCA)及其牛磺酸和甘氨酸共轭物更具胆汁淤积性。此外,LCA羟基化被认为是一种主要的解毒机制。因此,在LCA诱导的胆汁淤积发生及恢复过程中,对LCA葡萄糖醛酸化和羟基化的作用进行了研究。雄性大鼠静脉推注[14C]LCA(12 μmol/100 g体重),每30分钟收集一次胆汁样本,共收集5小时。注射LCA后胆汁流量(BF)立即降低,60分钟时降至基础BF的40%。然后开始增加,在3.5小时时达到正常胆汁流量值。形态学上,胆小管病变在60分钟时占主导,2小时时几乎不存在。在60分钟(最大胆汁淤积时),注射的LCA中有30%分泌到胆汁中,20%存在于血浆中,另外50%在肝脏中回收,主要分布在质膜、微粒体和胞质溶胶中。在实验结束时(正常BF),注射的LCA中有20%仍在肝脏中,但主要存在于胞质溶胶中。在胆汁中,注射后30分钟内,分泌的LCA中有46%是石胆酸葡萄糖醛酸苷,24%与牛磺酸和甘氨酸结合,21%是以羟基化胆汁酸的形式存在。在恢复期间,石胆酸葡萄糖醛酸苷的分泌降至18 - 25%。牛磺酸和甘氨酸共轭物的分泌在60分钟时增加到最大值43%,之后降至21 - 28%。相比之下,羟基化代谢产物在恢复期间升高,在120分钟时达到最大值(45%),此后保持恒定。这些结果表明:(i)LCA与质膜和微粒体的结合似乎与胆汁淤积的发生相关;(ii)LCA葡萄糖醛酸化可能引发和/或促成LCA诱导的胆汁淤积;(iii)在胆汁淤积恢复过程中羟基化占主导。